Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
Raltegravir susceptibility and fitness progression of HIV type-1 integrase in patients on long-term antiretroviral therapy.
HIV-1 gp41 fusogenic function triggers autophagy in uninfected cells.
Maturation of blood-derived dendritic cells enhances human immunodeficiency virus type 1 capture and transmission.
The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy.
Inhibition of human immunodeficiency virus type 1 infection in macrophages by an alpha-v integrin blocking antibody.
Treatment of monocytes with interleukin (IL)-12 plus IL-18 stimulates survival, differentiation and the production of CXC chemokine ligands (CXCL)8, CXCL9 and CXCL10.
Inhibition of coreceptor-independent cell-to-cell human immunodeficiency virus type 1 transmission by a CD4-immunoglobulin G2 fusion protein.
Multiparametric assay to screen and dissect the mode of action of anti-human immunodeficiency virus envelope drugs.
R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
High level of coreceptor-independent HIV transfer induced by contacts between primary CD4 T cells.